Venous thromboembolism associated with double heterozygosity for R506Q mutation of factor V and for T298M mutation of protein C in a large family of a previously described homozygous protein C-deficient newborn with massive thrombosis

Blood

Volumn 88, Issue 3, 1996, Pages 877-880

  Brenner, Benjamin ^a   Zivelin, Ariella ^b   Lanir, Naomi ^b   Greengard, Judith S ^b   Griffin, John H ^b   Seligsohn, Uri ^b  

^a RAMBAM MEDICAL CENTER   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5; PROTEIN C;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; FAMILIAL DISEASE; FATALITY; FEMALE; GENE MUTATION; HETEROZYGOSITY; HUMAN; MALE; MOLECULAR MODEL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; RESTRICTION MAPPING; THROMBOEMBOLISM; VEIN THROMBOSIS;

EID: 0029743426     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.3.877.877     Document Type: Article

References (28)

1. Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C: Deficiency of protein C in congenital thrombotic disease. J Clin Invest 68:1370, 1981
2. Branson HE, Katz HJ, Marble R, Griffin JH: Inherited protein C deficiency and coumarin-responsive chronic relapsing purpura fulminans in a newborn infant. Lancet 2:1165, 1983
3. Seligsohn U, Berger A, Abend M, Rubin L, Attias D, Zivelin A, Rapaport SI: Homozygous protein C deficiency manifested by massive venous thrombosis in the newborn. N Engl J Med 310:559, 1984
4. Miletich J, Sherman L, Broze G: Absence of thrombosis in subjects with heterozygous protein C deficiency. N Engl J Med 317:991, 1987
5. Ben-Tal O, Zivelin A, Seligsohn U: The relative frequency of hereditary thrombotic disorders among 107 patients with thrombophilia in Israel. Thromb Haemost 61:50, 1989
6. Dahlbäck B, Carlsson M, Svensson PJ: Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 90:1004, 1993
7. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64, 1994
8. Greengard JS, Sun X, Xu X, Fernandez JA, Griffin JH, Evatt B: Activated protein C resistance caused by Arg506Gln mutation in factor Va. Lancet 343:1361, 1994
9. Voorberg J, Roelse J, Koopman R, Buller H, Berends F, ten Gate JW, Mertens K, van Mourik JA: Association of idiopathic venous thromboembolism with single point-mutation at Arg 506 of factor V. Lancet 343:1535, 1994
10. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215, 1988
11. Greengard JS, Eichinger S, Griffin JH, Bauer KA: Brief report: Variability of thrombosis among homozygous siblings with resistance to activated protein C due to an Arg → Gln mutation in the gene for factor V. N Engl J Med 331:1159, 1994
12. Tsay W, Greengard JS, Montgomery RR, McPherson RA, Fucci JC, Koerper MA, Coughlin J, Griffin JH: Genetic mutations in ten unrelated American patients with symptomatic type I protein C deficiency. Blood Coagul Fibrinolysis 4:791, 1993
13. Griffin JH, Evatt B, Wideman C, Fernandez JA: Anticoagulant protein C pathway is defective in majority of thrombophilic patients. Blood 82:1989, 1993
14. Koster T, Rosendaal FR, de Ronde H, Briet E, Vanden-broucke JP, Bertina RM: Venous thrombosis due to poor anticoagulant response to activated protein C; Leiden Thrombophilia Study. Lancet 342:1503, 1993
15. Svensson PJ, Dahlbäck B: Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 330:517, 1994
16. Tomczak JA, Ando RA, Sobel HG, Bovill EG, Long GL: Genetic analysis of a large kindred exhibiting type I protein C deficiency and associated thrombosis. Thromb Res 74:243, 1994
17. Tait RC, Walker ID, Reitsma PH, Islam SIAM, McCall F, Poort SR, Conkie JA, Bertina RM: Prevalence of protein C deficiency in the healthy population. Thromb Haemost 73:87, 1995
18. Tuddenham EGD, Takase T, Thomas AE, Awidi AS, Madanat FF, Hajir MMA, Kernoff PBA, Hoffbrand AV: Homozygous protein C deficiency with delayed onset of symptoms at 7 to 10 months. Thromb Res 53:475, 1989
19. Reitsma PH, Bernardi F, Doig RG, Gandrille S, Greengard JS, Ireland H, Krawczak M, Lind B, Long GL, Poort SR, Saito H, Sala N, Witt I, Cooper DN: Protein C deficiency: A database of mutations, 1995 update. Thromb Haemost 73:876, 1995
20. Koeleman BPC, Reitsma PH, Allaart CF, Bertina RM: Activated protein C resistance as an additional risk factor for thrombosis in protein C deficient families. Blood 84:1031, 1994
21. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP: Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 332:912, 1995
22. Koster T, Rosendaal RF, Briet E, Van der Meer FJM, Colly LP, Trienekens PH, Poort SR, Reitsma PH, Vandenbrouke JP: Protein C deficiency in a controlled series of unselected out patients: An infrequent but clear risk factor for venous thrombosis. Blood 85:2756, 1995
23. Gandrille S, Greengard JS, Alhenc-Gelas M, Juhan-Vague I, Abgrall JF, Jude B, Griffin JH, Aiach M and the French network on behalf of INSERM: Molecular abnormalities responsible for protein C and protein S deficiencies. Incidence of activated protein C resistance due to the Arg506 Gln mutation in factor V in 113 unrelated symptomatic protein C deficient patients. Blood 86:219, 1995
24. Greengard JS, Fisher CL, Villoutreix B, Griffin JH: Structural basis for type I and type II deficiencies of antithrombotic plasma protein C: Patterns revealed by three-dimensional molecular modelling of mutations of the protease domain. Proteins 18:367, 1994
25. Sun X, Evatt B, Griffin JH: Blood coagulation factor Va abnormality associated with resistance to activated protein C in venous thrombophilia. Blood 83:3120, 1994
26. Heeb MJ, Kojima Y, Greengard J, Griffin JH: Activated protein C resistance: Molecular mechanisms based on studies using purified Gln 506 factor V. Blood 85:3405, 1995
27. Kalafatis M, Bertina RM, Rand MD, Mann KG: Characterization of the molecular defect in factor V R506Q. J Biol Chem 270:4053, 1995
28. Kalafatis M, Rand MD, Mann KG: The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem 269:31869, 1994